Compile Data Set for Download or QSAR
Report error Found 64 Enz. Inhib. hit(s) with all data for entry = 2077
TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 50069762BDBM50069762(CHEMBL3182437 | ML323 | US9802904, 87)
Affinity DataIC50: 17nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 352028BDBM352028(US9802904, 89)
Affinity DataIC50: 34nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 352011BDBM352011(US9802904, 72)
Affinity DataIC50: 43nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350387BDBM350387(US9802904, 60)
Affinity DataIC50: 43nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 352013BDBM352013(US9802904, 74)
Affinity DataIC50: 48nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 352018BDBM352018(US9802904, 79)
Affinity DataIC50: 61nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 352025BDBM352025(US9802904, 86)
Affinity DataIC50: 61nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 351737BDBM351737(US9802904, 61)
Affinity DataIC50: 61nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350386BDBM350386(US9802904, 59)
Affinity DataIC50: 68nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 50069762BDBM50069762(CHEMBL3182437 | ML323 | US9802904, 87)
Affinity DataIC50: 76nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 351922BDBM351922(US9802904, 64)
Affinity DataIC50: 86nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350377BDBM350377(US9802904, 51)
Affinity DataIC50: 120nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350385BDBM350385(US9802904, 59)
Affinity DataIC50: 120nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 352015BDBM352015(US9802904, 76)
Affinity DataIC50: 120nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 351934BDBM351934(US9802904, 66)
Affinity DataIC50: 140nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 351941BDBM351941(US9802904, 67)
Affinity DataIC50: 140nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350383BDBM350383(US9802904, 57)
Affinity DataIC50: 140nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 351827BDBM351827(US9802904, 63)
Affinity DataIC50: 150nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350384BDBM350384(US9802904, 58)
Affinity DataIC50: 150nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 352027BDBM352027(US9802904, 88)
Affinity DataIC50: 150nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 352029BDBM352029(US9802904, 90)
Affinity DataIC50: 190nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 351968BDBM351968(US9802904, 69)
Affinity DataIC50: 220nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350381BDBM350381(US9802904, 55)
Affinity DataIC50: 220nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 352021BDBM352021(US9802904, 82)
Affinity DataIC50: 240nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350378BDBM350378(US9802904, 52)
Affinity DataIC50: 240nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 351779BDBM351779(US9802904, 62)
Affinity DataIC50: 270nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350376BDBM350376(US9802904, 50)
Affinity DataIC50: 340nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 352012BDBM352012(US9802904, 73)
Affinity DataIC50: 380nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 351932BDBM351932(US9802904, 65)
Affinity DataIC50: 480nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350368BDBM350368(US9802904, 19)
Affinity DataIC50: 480nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350382BDBM350382(US9802904, 56)
Affinity DataIC50: 480nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 352017BDBM352017(US9802904, 78)
Affinity DataIC50: 480nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350369BDBM350369(US9802904, 20 | US9802904, 21)
Affinity DataIC50: 610nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 352008BDBM352008(US9802904, 70)
Affinity DataIC50: 1.10E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350365BDBM350365(US9802904, 16)
Affinity DataIC50: 1.40E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350380BDBM350380(US9802904, 54)
Affinity DataIC50: 1.50E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350367BDBM350367(US9802904, 18)
Affinity DataIC50: 1.70E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350369BDBM350369(US9802904, 20 | US9802904, 21)
Affinity DataIC50: 1.90E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350379BDBM350379(US9802904, 53)
Affinity DataIC50: 2.12E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 351954BDBM351954(US9802904, 68)
Affinity DataIC50: 2.20E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350366BDBM350366(US9802904, 17)
Affinity DataIC50: 2.20E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350371BDBM350371(US9802904, 22)
Affinity DataIC50: 2.20E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 352014BDBM352014(US9802904, 75)
Affinity DataIC50: 2.20E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350357BDBM350357(US9802904, 9)
Affinity DataIC50: 2.40E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350353BDBM350353(US9802904, 5)
Affinity DataIC50: 2.40E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350359BDBM350359(US9802904, 10)
Affinity DataIC50: 3.00E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350356BDBM350356(US9802904, 8)
Affinity DataIC50: 3.00E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350354BDBM350354(US9802904, 6)
Affinity DataIC50: 3.00E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350363BDBM350363(US9802904, 14)
Affinity DataIC50: 3.40E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Department Of Health And Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350374BDBM350374(US9802904, 24)
Affinity DataIC50: 4.30E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

Displayed 1 to 50 (of 64 total ) | Next | Last >>
Jump to: